A detailed history of Retirement Planning Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Retirement Planning Group holds 4,643 shares of ABBV stock, worth $902,042. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,643
Previous 4,623 0.43%
Holding current value
$902,042
Previous $841,000 5.35%
% of portfolio
0.06%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $3,095 - $3,615
20 Added 0.43%
4,643 $796,000
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $2,716 - $3,095
17 Added 0.37%
4,623 $841,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $1,926 - $2,169
14 Added 0.3%
4,606 $713,000
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $133 - $154
-1 Reduced 0.02%
4,592 $684,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $6,492 - $8,080
-49 Reduced 1.06%
4,593 $618,000
Q1 2023

Apr 19, 2023

SELL
$144.61 - $166.54 $4,627 - $5,329
-32 Reduced 0.68%
4,642 $739,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $5,255 - $6,303
38 Added 0.82%
4,674 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $7,784 - $8,927
58 Added 1.27%
4,636 $622,000
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $5,917 - $7,523
-43 Reduced 0.93%
4,578 $701,000
Q1 2022

Apr 19, 2022

BUY
$131.98 - $163.75 $923 - $1,146
7 Added 0.15%
4,621 $749,000
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $859 - $1,087
8 Added 0.17%
4,614 $625,000
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $227,270 - $257,986
2,136 Added 86.48%
4,606 $497,000
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $259,868 - $289,508
2,470 New
2,470 $278,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Retirement Planning Group Portfolio

Follow Retirement Planning Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning Group, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning Group with notifications on news.